These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 38937742)

  • 1. WZ-3146 acts as a novel small molecule inhibitor of KIF4A to inhibit glioma progression by inducing apoptosis.
    Yan T; Jiang Q; Ni G; Ma H; Meng Y; Kang G; Xu M; Peng F; Li H; Chen X; Wang M
    Cancer Cell Int; 2024 Jun; 24(1):221. PubMed ID: 38937742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of hyaluronic acid degradation pathway suppresses glioma progression by inducing apoptosis and cell cycle arrest.
    Yan T; Yang H; Xu C; Liu J; Meng Y; Jiang Q; Li J; Kang G; Zhou L; Xiao S; Xue Y; Xu J; Chen X; Che F
    Cancer Cell Int; 2023 Aug; 23(1):163. PubMed ID: 37568202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KIF4A promotes epithelial-mesenchymal transition by activating the TGF-β/SMAD signaling pathway in glioma cells.
    Xu Y; Xue G; Zhou L; Wu G; Hu L; Ma S; Zhang J; Li X
    Mol Cell Biochem; 2024 Feb; ():. PubMed ID: 38411896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of core genes as potential biomarkers for predicting progression and prognosis in glioblastoma.
    Zeng J; Hua S; Liu J; Mungur R; He Y; Feng J
    Front Genet; 2022; 13():928407. PubMed ID: 36238156
    [No Abstract]   [Full Text] [Related]  

  • 5. KIF4A enhanced cell proliferation and migration via Hippo signaling and predicted a poor prognosis in esophageal squamous cell carcinoma.
    Sun X; Chen P; Chen X; Yang W; Chen X; Zhou W; Huang D; Cheng Y
    Thorac Cancer; 2021 Feb; 12(4):512-524. PubMed ID: 33350074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KIF4A drives gliomas growth by transcriptional repression of Rac1/Cdc42 to induce cytoskeletal remodeling in glioma cells.
    Zhang H; Meng S; Chu K; Chu S; Fan YC; Bai J; Yu ZQ
    J Cancer; 2022; 13(15):3640-3651. PubMed ID: 36606197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knockdown of kinesin family member 4A inhibits cell proliferation, migration, and invasion while promoting apoptosis of urothelial bladder carcinoma cells.
    Zhang C; Wang M; Ying Y; Meng F; Gao H; Zeng S; Zhu Y; Liu A; Zhang Z; Xu C
    Cancer Med; 2023 Jun; 12(11):12581-12592. PubMed ID: 37039264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-29c-3p regulates proliferation and migration in ovarian cancer by targeting KIF4A.
    Feng S; Luo S; Ji C; Shi J
    World J Surg Oncol; 2020 Dec; 18(1):315. PubMed ID: 33261630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-379-5p inhibits the proliferation, migration, and invasion of breast cancer by targeting KIF4A.
    Yang K; Li D; Jia W; Song Y; Sun N; Wang J; Li H; Yin C
    Thorac Cancer; 2022 Jul; 13(13):1916-1924. PubMed ID: 35608059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of KIF4A and its effect on the progression of lung adenocarcinoma based on the bioinformatics analysis.
    Song Y; Tang W; Li H
    Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33398330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of Driver Genes and Key Pathways of Glioblastoma Shows JNJ-7706621 as a Novel Antiglioblastoma Drug.
    Zhong S; Wu B; Dong X; Han Y; Jiang S; Zhang Y; Bai Y; Luo SX; Chen Y; Zhang H; Zhao G
    World Neurosurg; 2018 Jan; 109():e329-e342. PubMed ID: 28989042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer.
    Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y
    J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FOXM1 promotes hepatocellular carcinoma progression by regulating KIF4A expression.
    Hu G; Yan Z; Zhang C; Cheng M; Yan Y; Wang Y; Deng L; Lu Q; Luo S
    J Exp Clin Cancer Res; 2019 May; 38(1):188. PubMed ID: 31072351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrative analysis of KIF4A, 9, 18A, and 23 and their clinical significance in low-grade glioma and glioblastoma.
    Cho SY; Kim S; Kim G; Singh P; Kim DW
    Sci Rep; 2019 Mar; 9(1):4599. PubMed ID: 30872592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Value and Immune-Infiltration Pattern of
    Yang Z; Shen X; Luo S; Li Y
    Dis Markers; 2022; 2022():9621701. PubMed ID: 35126794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. KIF4A Promotes Clear Cell Renal Cell Carcinoma (ccRCC) Proliferation in vitro and in vivo.
    Yang GH; Ren ZX; Yang X; Zhang YG
    Onco Targets Ther; 2020; 13():2667-2676. PubMed ID: 32280241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. KIF4A knockdown suppresses ovarian cancer cell proliferation and induces apoptosis by downregulating BUB1 expression.
    Jin W; Ye L
    Mol Med Rep; 2021 Jul; 24(1):. PubMed ID: 34013367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormal expression of
    Wang J; Liu Z; Zhang C; Wang H; Li A; Liu B; Lian X; Ren Z; Zhang W; Wang Y; Zhang B; Pang B; Gao Y
    PeerJ; 2021; 9():e10820. PubMed ID: 33614284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cullin-7 (CUL7) is overexpressed in glioma cells and promotes tumorigenesis via NF-κB activation.
    Xu J; Zhang Z; Qian M; Wang S; Qiu W; Chen Z; Sun Z; Xiong Y; Wang C; Sun X; Zhao R; Xue H; Li G
    J Exp Clin Cancer Res; 2020 Apr; 39(1):59. PubMed ID: 32252802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KIF4A Regulates the Progression of Pancreatic Ductal Adenocarcinoma through Proliferation and Invasion.
    Chen J; Zhao CC; Chen FR; Feng GW; Luo F; Jiang T
    Biomed Res Int; 2021; 2021():8249293. PubMed ID: 34805404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.